Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 1.88
RMD's Cash to Debt is ranked higher than
54% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.42 vs. RMD: 1.88 )
Ranked among companies with meaningful Cash to Debt only.
RMD' s 10-Year Cash to Debt Range
Min: 0.33   Max: No Debt
Current: 1.88

Equity to Asset 0.67
RMD's Equity to Asset is ranked higher than
64% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. RMD: 0.67 )
Ranked among companies with meaningful Equity to Asset only.
RMD' s 10-Year Equity to Asset Range
Min: 0.34   Max: 0.86
Current: 0.67

0.34
0.86
Interest Coverage 66.09
RMD's Interest Coverage is ranked higher than
51% of the 103 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 56.06 vs. RMD: 66.09 )
Ranked among companies with meaningful Interest Coverage only.
RMD' s 10-Year Interest Coverage Range
Min: 26.38   Max: 9999.99
Current: 66.09

26.38
9999.99
F-Score: 6
Z-Score: 9.73
M-Score: -2.64
WACC vs ROIC
6.65%
28.65%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 24.87
RMD's Operating margin (%) is ranked higher than
92% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.85 vs. RMD: 24.87 )
Ranked among companies with meaningful Operating margin (%) only.
RMD' s 10-Year Operating margin (%) Range
Min: -25.07   Max: 28.66
Current: 24.87

-25.07
28.66
Net-margin (%) 21.52
RMD's Net-margin (%) is ranked higher than
91% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.03 vs. RMD: 21.52 )
Ranked among companies with meaningful Net-margin (%) only.
RMD' s 10-Year Net-margin (%) Range
Min: 7.5   Max: 22.2
Current: 21.52

7.5
22.2
ROE (%) 21.46
RMD's ROE (%) is ranked higher than
90% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.27 vs. RMD: 21.46 )
Ranked among companies with meaningful ROE (%) only.
RMD' s 10-Year ROE (%) Range
Min: 7.94   Max: 26.85
Current: 21.46

7.94
26.85
ROA (%) 15.17
RMD's ROA (%) is ranked higher than
91% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.87 vs. RMD: 15.17 )
Ranked among companies with meaningful ROA (%) only.
RMD' s 10-Year ROA (%) Range
Min: 5.76   Max: 21.63
Current: 15.17

5.76
21.63
ROC (Joel Greenblatt) (%) 50.00
RMD's ROC (Joel Greenblatt) (%) is ranked higher than
85% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.74 vs. RMD: 50.00 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
RMD' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -44.93   Max: 68.56
Current: 50

-44.93
68.56
Revenue Growth (3Y)(%) 10.80
RMD's Revenue Growth (3Y)(%) is ranked higher than
78% of the 145 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.70 vs. RMD: 10.80 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
RMD' s 10-Year Revenue Growth (3Y)(%) Range
Min: 10.8   Max: 31.8
Current: 10.8

10.8
31.8
EBITDA Growth (3Y)(%) 14.00
RMD's EBITDA Growth (3Y)(%) is ranked higher than
64% of the 119 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.70 vs. RMD: 14.00 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
RMD' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 5.9   Max: 81.7
Current: 14

5.9
81.7
EPS Growth (3Y)(%) 18.40
RMD's EPS Growth (3Y)(%) is ranked higher than
68% of the 119 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.20 vs. RMD: 18.40 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
RMD' s 10-Year EPS Growth (3Y)(%) Range
Min: 0   Max: 65.8
Current: 18.4

0
65.8
» RMD's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

RMD Guru Trades in Q2 2014

Chuck Royce 48,333 sh (+3.28%)
Jeremy Grantham 175,314 sh (+2.63%)
Chase Coleman 1,000,000 sh (unchged)
Jim Simons Sold Out
Paul Tudor Jones Sold Out
First Eagle Investment Sold Out
Joel Greenblatt 18,321 sh (-96.54%)
» More
Q3 2014

RMD Guru Trades in Q3 2014

Chase Coleman 1,000,000 sh (unchged)
Joel Greenblatt Sold Out
Chuck Royce 47,368 sh (-2.00%)
Jeremy Grantham 134,714 sh (-23.16%)
» More
Q4 2014

RMD Guru Trades in Q4 2014

Paul Tudor Jones 5,100 sh (New)
John Hussman 3,500 sh (New)
Steven Cohen 215,700 sh (New)
Jim Simons 452,900 sh (New)
Chuck Royce Sold Out
Chase Coleman Sold Out
Jeremy Grantham 110,903 sh (-17.68%)
» More
Q1 2015

RMD Guru Trades in Q1 2015

John Hussman 3,500 sh (unchged)
Paul Tudor Jones Sold Out
Steven Cohen Sold Out
Jeremy Grantham 110,703 sh (-0.18%)
Jim Simons 83,100 sh (-81.65%)
» More
» Details

Insider Trades

Latest Guru Trades with RMD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 23.60
RMD's P/E(ttm) is ranked higher than
67% of the 108 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. RMD: 23.60 )
Ranked among companies with meaningful P/E(ttm) only.
RMD' s 10-Year P/E(ttm) Range
Min: 16.9   Max: 66.2
Current: 23.6

16.9
66.2
Forward P/E 46.30
RMD's Forward P/E is ranked higher than
98% of the 83 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.28 vs. RMD: 46.30 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 23.10
RMD's PE(NRI) is ranked higher than
67% of the 109 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.40 vs. RMD: 23.10 )
Ranked among companies with meaningful PE(NRI) only.
RMD' s 10-Year PE(NRI) Range
Min: 16.93   Max: 66.36
Current: 23.1

16.93
66.36
P/B 5.30
RMD's P/B is ranked lower than
105% of the 164 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. RMD: 5.30 )
Ranked among companies with meaningful P/B only.
RMD' s 10-Year P/B Range
Min: 2.29   Max: 6.86
Current: 5.3

2.29
6.86
P/S 5.10
RMD's P/S is ranked lower than
114% of the 154 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.75 vs. RMD: 5.10 )
Ranked among companies with meaningful P/S only.
RMD' s 10-Year P/S Range
Min: 2.78   Max: 6.93
Current: 5.1

2.78
6.93
PFCF 26.00
RMD's PFCF is ranked lower than
59% of the 81 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. RMD: 26.00 )
Ranked among companies with meaningful PFCF only.
RMD' s 10-Year PFCF Range
Min: 13.43   Max: 284.56
Current: 26

13.43
284.56
POCF 20.31
RMD's POCF is ranked lower than
60% of the 108 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.50 vs. RMD: 20.31 )
Ranked among companies with meaningful POCF only.
RMD' s 10-Year POCF Range
Min: 10.7   Max: 51.06
Current: 20.31

10.7
51.06
EV-to-EBIT 18.71
RMD's EV-to-EBIT is ranked higher than
61% of the 114 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.40 vs. RMD: 18.71 )
Ranked among companies with meaningful EV-to-EBIT only.
RMD' s 10-Year EV-to-EBIT Range
Min: 12.4   Max: 48.5
Current: 18.71

12.4
48.5
PEG 1.31
RMD's PEG is ranked higher than
80% of the 59 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.88 vs. RMD: 1.31 )
Ranked among companies with meaningful PEG only.
RMD' s 10-Year PEG Range
Min: 0.64   Max: 5.64
Current: 1.31

0.64
5.64
Shiller P/E 31.20
RMD's Shiller P/E is ranked lower than
64% of the 81 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.32 vs. RMD: 31.20 )
Ranked among companies with meaningful Shiller P/E only.
RMD' s 10-Year Shiller P/E Range
Min: 24.48   Max: 67.17
Current: 31.2

24.48
67.17
Current Ratio 6.06
RMD's Current Ratio is ranked higher than
86% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.55 vs. RMD: 6.06 )
Ranked among companies with meaningful Current Ratio only.
RMD' s 10-Year Current Ratio Range
Min: 0.87   Max: 6.44
Current: 6.06

0.87
6.44
Quick Ratio 5.18
RMD's Quick Ratio is ranked higher than
87% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.62 vs. RMD: 5.18 )
Ranked among companies with meaningful Quick Ratio only.
RMD' s 10-Year Quick Ratio Range
Min: 0.61   Max: 5.71
Current: 5.18

0.61
5.71
Days Inventory 112.88
RMD's Days Inventory is ranked higher than
57% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 121.06 vs. RMD: 112.88 )
Ranked among companies with meaningful Days Inventory only.
RMD' s 10-Year Days Inventory Range
Min: 100.51   Max: 183.38
Current: 112.88

100.51
183.38
Days Sales Outstanding 76.84
RMD's Days Sales Outstanding is ranked lower than
71% of the 156 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.58 vs. RMD: 76.84 )
Ranked among companies with meaningful Days Sales Outstanding only.
RMD' s 10-Year Days Sales Outstanding Range
Min: 57.87   Max: 89.17
Current: 76.84

57.87
89.17

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.90
RMD's Dividend Yield is ranked higher than
61% of the 84 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. RMD: 1.90 )
Ranked among companies with meaningful Dividend Yield only.
RMD' s 10-Year Dividend Yield Range
Min: 0.41   Max: 2.2
Current: 1.9

0.41
2.2
Dividend Payout 0.44
RMD's Dividend Payout is ranked higher than
53% of the 73 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.30 vs. RMD: 0.44 )
Ranked among companies with meaningful Dividend Payout only.
RMD' s 10-Year Dividend Payout Range
Min: 0.29   Max: 0.48
Current: 0.44

0.29
0.48
Yield on cost (5-Year) 1.90
RMD's Yield on cost (5-Year) is ranked lower than
61% of the 87 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.60 vs. RMD: 1.90 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
RMD' s 10-Year Yield on cost (5-Year) Range
Min: 0.41   Max: 2.2
Current: 1.9

0.41
2.2
Share Buyback Rate 2.80
RMD's Share Buyback Rate is ranked higher than
91% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.80 vs. RMD: 2.80 )
Ranked among companies with meaningful Share Buyback Rate only.
RMD' s 10-Year Share Buyback Rate Range
Min: 2.8   Max: -3.9
Current: 2.8

Valuation & Return

vs
industry
vs
history
Price/Net Cash 66.60
RMD's Price/Net Cash is ranked lower than
111% of the 47 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.00 vs. RMD: 66.60 )
Ranked among companies with meaningful Price/Net Cash only.
RMD' s 10-Year Price/Net Cash Range
Min: 11.81   Max: 301.29
Current: 66.6

11.81
301.29
Price/Net Current Asset Value 16.70
RMD's Price/Net Current Asset Value is ranked lower than
84% of the 69 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. RMD: 16.70 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
RMD' s 10-Year Price/Net Current Asset Value Range
Min: 1.63   Max: 1340
Current: 16.7

1.63
1340
Price/Tangible Book 6.70
RMD's Price/Tangible Book is ranked lower than
86% of the 149 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.20 vs. RMD: 6.70 )
Ranked among companies with meaningful Price/Tangible Book only.
RMD' s 10-Year Price/Tangible Book Range
Min: 1.5   Max: 35.03
Current: 6.7

1.5
35.03
Price/DCF (Projected) 1.60
RMD's Price/DCF (Projected) is ranked lower than
55% of the 92 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.40 vs. RMD: 1.60 )
Ranked among companies with meaningful Price/DCF (Projected) only.
RMD' s 10-Year Price/DCF (Projected) Range
Min: 1.34   Max: 22.58
Current: 1.6

1.34
22.58
Price/Median PS Value 1.10
RMD's Price/Median PS Value is ranked higher than
57% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.00 vs. RMD: 1.10 )
Ranked among companies with meaningful Price/Median PS Value only.
RMD' s 10-Year Price/Median PS Value Range
Min: 0.49   Max: 2.57
Current: 1.1

0.49
2.57
Price/Peter Lynch Fair Value 1.60
RMD's Price/Peter Lynch Fair Value is ranked higher than
69% of the 42 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. RMD: 1.60 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
RMD' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.7   Max: 6.74
Current: 1.6

0.7
6.74
Price/Graham Number 2.60
RMD's Price/Graham Number is ranked lower than
52% of the 88 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. RMD: 2.60 )
Ranked among companies with meaningful Price/Graham Number only.
RMD' s 10-Year Price/Graham Number Range
Min: 1.47   Max: 14.66
Current: 2.6

1.47
14.66
Earnings Yield (Greenblatt) 5.30
RMD's Earnings Yield (Greenblatt) is ranked higher than
74% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. RMD: 5.30 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
RMD' s 10-Year Earnings Yield (Greenblatt) Range
Min: 2.1   Max: 8.1
Current: 5.3

2.1
8.1
Forward Rate of Return (Yacktman) 18.56
RMD's Forward Rate of Return (Yacktman) is ranked higher than
74% of the 86 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.90 vs. RMD: 18.56 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) only.
RMD' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 12.2   Max: 31.2
Current: 18.56

12.2
31.2

Analyst Estimate

Jun15 Jun16 Jun17
Revenue(Mil) 1,645 1,757 1,689
EPS($) 1.16 1.26 0.27
EPS without NRI($) 1.16 1.26 0.27

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:RMD.Australia, RME.Germany, RMEA.Germany, RSMDF.USA,
ResMed Inc a Delaware corporation was formed in March 1994. The Company is engaged in the development, manufacturing, distribution and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing, or SDB. SDB includes obstructive sleep apnea, or OSA, and other respiratory disorders that occur during sleep. SDB includes obstructive sleep apnea, or OSA, and other respiratory disorders that occur during sleep. The Company markets its products in more than 100 countries to sleep clinics, home healthcare dealers and third-party payors. It also market the products directly to sleep clinics. The Company's portfolio of products includes airflow generators, diagnostic products, mask systems, headgear and other accessories. The Company produces CPAP, VPAP and AutoSet systems for the titration and treatment of SDB. The flow generator systems deliver positive airway pressure through a patient interface, either a small nasal mask, nasal pillows system, or full-face mask. The Company's competitors include Philips BV; DeVilbiss Healthcare; Fisher & Paykel Healthcare Corporation Limited; Apex Medical Corporation; BMC Medical Co. Ltd.; and regional manufacturers. The Company's products are subject to extensive regulation particularly as to safety, efficacy and adherence to FDA Quality System Regulation, and related manufacturing standards. Medical device products are subject to rigorous FDA and other governmental agency regulations in the United States and similar regulations of foreign agencies abroad.
» More Articles for RMD

Headlines

Articles On GuruFocus.com
Hologic Produces the First FDA-Approved 3D Mammography Platform Nov 26 2014 
These 7 Growth Stocks Have Potential To Make You Rich Sep 14 2014 
Buy ResMed and Sleep Tight (Like Jim Simons) Feb 02 2014 
3 Cheap Health Care Dividend Stocks with Huge Potential to Grow Dividends Oct 02 2013 
Meeting the Herd Mar 25 2013 
The Best Yielding Ex-Dividend Stocks on February 14, 2013 Feb 13 2013 
Weekly CEO Sells Highlight: ResMed Inc., Chuy’s Holdings Inc., Electronics for Imaging Inc., Coher Feb 04 2013 
ResMed - Growing Business with Consistent Cash Flow Generation at Lowest 10-Year Valuation Jan 24 2012 
predictable hussma Sep 30 2011 
Weekly CFO Sells Highlight: RMD, CATM, HXL, BCR, AMRC Jul 24 2011 

More From Other Websites
Australia shares bounce as investors swoop on discounts after 2-month rout May 20 2015
The week in numbers to May 15 May 14 2015
Resmed punished on sleep trial failure May 14 2015
Resmed plunges on sleep therapy fears May 13 2015
ResMed (RMD) Stock Falls After Sleep Apnea Treatment Misses Primary Endpoint in Phase III Trial May 13 2015
ResMed downgraded by BofA/Merrill May 13 2015
RESMED INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits May 13 2015
ResMed Provides Update on Phase III SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy In... May 13 2015
ResMed Provides Update on Phase III SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy In... May 13 2015
ResMed Provides Update on Phase III SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy In... May 13 2015
Oceania & ASEAN Respiratory Market to Boost APAC Region Owing to Rising Chronic Respiratory Diseases... May 05 2015
10-Q for ResMed, Inc. May 01 2015
ResMed Introduces Lumis Series of Noninvasive Ventilators for Personalized, Simplified and Connected... Apr 30 2015
ResMed Introduces Lumis Series of Noninvasive Ventilators for Personalized, Simplified and Connected... Apr 30 2015
RESMED INC Files SEC form 10-Q, Quarterly Report Apr 29 2015
Australia shares drop for the second straight session Apr 28 2015
Australia shares retreat as key 6,000 mark remains out of reach Apr 27 2015
ResMed Beats Q3 Earnings by a Penny, Misses on Revenues - Analyst Blog Apr 24 2015
Australia shares jump on commodity rally Apr 23 2015
ResMed beats 3Q profit forecasts Apr 23 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK